Discussion of individual bioequivalence by M.-L. chen
Author:
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 7 (1) , 23-29
Abstract
We review and discuss some technical statistical issues and practical implementation issues associated with the use of individual as opposed to population average bioequivalence to express the relative bioavailabilities of alternative formulations of a drug. A number of promising methods for addressing individual bioequivalence have been described. Individual bioequivalence calculations can be done using standard crossover designs, although more sophisticated assessments that compare test-reference variability to reference-reference variability require more complex designs. However, more experience about the clinical implications of various degrees of individual bioinequivalence as expressed by various metrics should be accumulated before definitive regulations are set forth mandating the use of individual bioequivalence for expressing relative bioavailabilities.Keywords
This publication has 19 references indexed in Scilit:
- Moment-based criteria for determining bioequivalenceBiometrika, 1993
- Sample sizes for event rate equivalence trials using prior informationStatistics in Medicine, 1993
- Exact Inference about the Within-Subject Variability in 2 × 2 Crossover TrialsJournal of the American Statistical Association, 1993
- On population and individual bioequivalenceStatistics in Medicine, 1993
- Controversies in Bioequivalence StudiesClinical Pharmacokinetics, 1992
- Variance components in comparative bioavailability studiesJournal of Pharmaceutical Sciences, 1992
- On the assessment of variability in bioavailability/bioequivalence studiesCommunications in Statistics - Theory and Methods, 1992
- Illustration of Bayesian Inference in Normal Data Models Using Gibbs SamplingJournal of the American Statistical Association, 1990
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- GLC Determination of Ticrynafen and Its Metabolites in Urine, Serum, and Plasma of Humans and AnimalsJournal of Pharmaceutical Sciences, 1978